Sunshine Now on the Horizon

Yesterday, CMS started to make up for lost time when it issued the draft regulations on the Sunshine law in the Affordable Care Act. This new law requires manufacturers of drugs, medical devices (e.g. stents, replacement knees etc), and biologics to repor

The Affordable Care Act is Keeping Young Adults Healthy for the Holidays

Thanks to a key provision of the Affordable Care Act (ACA), 2.5 million young adults will be healthy for the holidays this year. As we’ve blogged about previously, the ACA allows most young adults under 26 to remain on their parents’ health plans if they

Weakening Affordability Protections (Again): The Wrong Way to Pay for the Doc-Fix

Congress must act before the end of the year to prevent an automatic 27 percent rate cut for Medicare doctors (the “doc-fix”, as it is generally known in DC). To pay for it, some Republican Members of Congress are floating the idea of further eroding heal

Economic Adulteration: All that Glitters isn't Gold

Recently, the Government Accountability Office published a report entitled, “Food and Drug Administration: Better Coordination Could Enhance Efforts to Address Economic Adulteration and Protect Public Health.” The report describes economic adulteration as

The Good, the Bad, and the Ugly: Disappointing New Federal Guidance on Health Insurance Exchanges

Earlier this week, the Centers for Medicare & Medicaid Services (CMS) issued sub-regulatory guidance aimed at clarifying some of the outstanding questions related to implementing health insurance Exchanges as part of the Affordable Care Act (ACA). On

Medicaid and the Children’s Health Insurance Program Buffer the Impact of the Recession on Children

In most respects, children have not been exempt from the impacts of the current economic downturn. The number of children living in poverty in the United States rose to 15.7 million in 2010—a 19 percent increase from 2008. Despite this bleak picture, a ne

31 Organizations Call for Safe Drug Manufacturing Reforms in PDUFA

Late yesterday, thirty advocacy organizations, representing seniors, labor, providers, patient safety advocates, cancer patients, and consumers joined Community Catalyst in calling for Congressional action to improve the safety of drug manufacturing.  In

Agreement to Support More Generic Drug Inspections Can Ensure Safety of Vital Drugs

In October, the FDA and manufacturers of finished generic drugs and ingredients (Active Pharmaceutical Ingredients or APIs) reached a ground breaking agreement that can (1) ensure the safety of generic drugs and APIs wherever they are produced globally an

Super Committee Failure: It Could Have Been Worse!

Late Monday, the 12 members of the Joint Select Committee on Deficit Reduction (aka the “Super Committee”) announced their failure to agree to a debt-reduction package. How should consumer health advocates react to the news? A Plague on Only One of Your